Editorial: Pathogenesis, immune escape, prognosis, and novel management of lymphoid proliferative disorders

Front Immunol. 2022 Nov 21:13:1063418. doi: 10.3389/fimmu.2022.1063418. eCollection 2022.

Author

Wei Sang¹

Affiliation

¹ Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.

No abstract available

Keywords: immune escape; lymphoid proliferative disorders; lymphoproliferative disease; pathogenesis; prognosis.

Publication types

Editorial

MeSH terms

Prognosis*